Chances are the first time you heard about the drug Daraprim was in 2015, when a young man by the name of Martin Shkreli purchased the patent and increased the price 5,000%. The stunt earned Shkreli the nickname “Pharma Bro” and made international headlines. A recent CNN article reported that the FDA has approved the first generic version of the drug.